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Summary
Diamond-Blackfan anemia (DBA) is a rare pure red-cell
hypoplasia of unknown etiology and pathogenesis. A
major DBA locus has previously been localized to chro-
mosome 19q13.2. Samples from additional families have
been collected to identify key recombinations, micro-
deletions, and the possibility of heterogeneity for the
disorder. In total, 29 multiplex DBA families and 50
families that comprise sporadic DBA cases have been
analyzed with polymorphic 19q13 markers, including a
newly identified short-tandem repeat in the critical gene
region. The results from DNA analysis of 29 multiplex
families revealed that 26 of these were consistent with
a DBA gene on 19q localized to within a 4.1-cM interval
restricted by loci D19S200 and D19S178; however, in
three multiplex families, the DBA candidate region on
19q13 was excluded from the segregation of marker
alleles. Our results suggest genetic heterogeneity for
DBA, and we show that a gene region on chromosome
19q segregates with the disease in themajority of familial
cases. Among the 50 families comprising sporadic DBA
cases, we identified two novel and overlapping micro-
deletions on chromosome 19q13. In combination, the
three known microdeletions associated with DBA re-
strict the critical gene region to ∼1 Mb. The results in-
dicate that a proportion of sporadic DBA cases are
caused by deletions in the 19q13 region.
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Introduction
Diamond-Blackfan anemia (DBA; MIM 205900) is
characterized by chronic constitutional aregenerative
anemia with absent or decreased red cell precursors in
the bone marrow but with otherwise normal cellularity
(Diamond and Blackfan 1938; Alter 1980; Halperin and
Freedman 1980; Young and Alter 1994). Most patients
present with anemia in the neonatal period or in infancy.
Additional findings frequently include macrocytosis, el-
evated fetal hemoglobin, and increased red-cell adeno-
sine deaminase (ADA; Glader and Backer 1988). As-
sociated physical anomalies are present in at least 30%
of children with DBA, with a wide range of severity.
Craniofacial abnormalities are common, with a cleft or
high-arched palate, hypertelorism, and a flat nasal bridge
(Cathie 1950). Thumb abnormalities are present in
10%–20% of affected children, range in severity from
flat thenar eminence to absent radii, and include the
classic triphalangeal thumb (Aase and Smith 1969).
Other defects frequently observed include atrial or ven-
tricular septal defects, prenatal or postnatal growth re-
tardation, urogenital anomalies, learning difficulties,
strabismus, and cataracts (Diamond et al. 1976; Hal-
perin and Freedman 1989; Young and Alter 1994; Ball
et al. 1996; Janov et al. 1996). Most cases of DBA are
sporadic, with an equal sex ratio, but at least 10% of
patients have a positive family history for the disorder
with either an autosomal dominant inheritance (Vis-
kochil et al. 1990; Gojic et al. 1990) or an apparently
autosomal recessive inheritance (Madanat et al. 1994).
There are also several reports of families that show dom-
inant inheritance with incomplete penetrance (Mott et
al. 1969; Altman and Gross 1983).
We recently identified a girl with a balanced trans-
location t(X;19)(p21;q13) associated with the disease
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Table 1
Two-point LOD Scores in Each Family between DBA and
Chromosome 19 Marker Locus D19S197 in Multiplex Families
Family/LOD Score Family/LOD Score Family/LOD Score
1/.30 11/.78 21/.26
2/.25 12/.30 22/.74
3/.26 13/.00 23/.30
4/.83 14/.74 24/n.i.
5/.26 15/n.i. 25/.74
6/.82 16/.74 26/(3.84)
7/n.i. 17/.26 27/(5.25)
8/.30 18/(4.94) 28/.26
9/.56 19/.18 29/.30
10/.90 20/.30
NOTE.—Recombination fraction ; . Ta-(v)  .00 Z  4.10(9.93)max
ble results from linkage analysis by use of a dominant model in all
families (penetrance .9). Families 1–13 were reported elsewhere (Gus-
tavsson et al. 1997b). LOD scores in parentheses (families 18, 26, and
27) correspond to families I–III (fig. 1) not linked to chromosome
19q13. Families 14, 16, 19, 22, and 25 correspond to families IV–VIII
(fig. 2) with possible incomplete penetrance. Families not informative
for D19S197 are indicated by “n.i.” In a different linkage analysis,
we used a dominant model for families that follow a dominant mode
of inheritance and a recessive model for families that follow a recessive
inheritance (families 11, 12, 13, and 29). With this combination of
either a dominant or a recessive model, was obtained.Z  5.84max
(Gustavsson et al. 1997a). On the basis of this obser-
vation, we performed a linkage analysis on multiplex
DBA families with chromosome 19q markers. The re-
sults showed linkage of the DBA phenotype to the chro-
mosomal region with a two-point maximum LOD score
(Zmax) of 7.08 for D19S197 and no indications of het-
erogeneity in familial cases (Gustavsson et al. 1997b).
Moreover, DNA analysis of one patient with sporadic
DBA revealed a de novo microdeletion that overlaps
with the translocation break point (Gustavsson et al.
1997b).
After the identification of the 19q13 region as a carrier
for a gene for DBA, additional DBA families were iden-
tified. DNA analysis of sporadic DBA cases revealed
hemizygosity for a critical gene region on 19q13 in two
additional patients. The complex phenotypes associated
with the overlapping microdeletions suggest the involve-
ment of genes for mental retardation and skeletal mal-
formations. The DNA-marker analysis of samples from
29 multiplex DBA families showed that in three families
linkage was excluded from the entire 19q13 region,
which indicates genetic heterogeneity.
Subjects and Methods
Subjects
Blood samples were obtained from unselected DBA
patients, their (healthy) siblings, and their parents. Of
the 79 families included in this study, 29 families in-
cluded 11 affected individual, whereas in 50 families
cases of DBA were sporadic. Thirteen families (families
1–13, table 1) of the 29 families with familial DBA were
included in a previous linkage study (Gustavsson et al.
1997b). Four families were consistent with an autosomal
recessive inheritance, and 25 families showed an auto-
somal dominant inheritance. All patients had been di-
agnosed in pediatric hematology/oncology departments
in their country of origin. The minimal diagnostic cri-
teria included normochromic anemia in infancy (!2
years), low reticulocyte counts, absent or decreased bone
marrow red-cell precursors (!5% of nucleated cells), and
a normal chromosome fragility test (mitomycin C or
diepoxybutane). Additional features included the pres-
ence of malformations, macrocytosis, elevated fetal he-
moglobin, and elevated erythrocyte ADA levels (Glader
and Backer 1988). Fetal hemoglobin and ADA were not
consistently determined in all family members, because
the tests were not available at some hospitals. The pa-
tients, with the exception of a few mildly affected family
members, were diagnosed before the age of 2 years.
Healthy family members aged !2 years were not in-
cluded in the linkage analysis. A variety of associated
malformations were identified among the affected pa-
tients, including skeletal anomalies of the hand and fore-
arm, heart defects, cataracts, and short stature. Mental
retardation associated with DBA was found in seven
sporadic cases. Family members were considered non-
affected if they had normal hemoglobin levels for x2
years, had no history of transient anemia or of trans-
fusion requirements, and had none of the associated
physical anomalies, including those revealed by clinical
examination of the hands. Coexistence of mild and se-
vere anemia was observed in several multiplex families.
One family has previously been described from a clinical
point of view (family VII, fig. 2; Mott et al. 1969).
Fanconi anemia was excluded by chromosome fra-
gility test (mitomycin C or diepoxybutane) in at least
one affected member per family (frequency of breakage
!10%). The same individuals were also karyotyped by
conventional cytogenetic studies. One sporadic DBA pa-
tient had an apparently balanced de novo translocation,
t(8;19)(q35;q13). Lymphoblastoid cell lines were estab-
lished for further genetic analysis from the peripheral
blood of a few patients by transformation with the Ep-
stein-Barr virus.
Identification of a Novel Microsatellite Marker
Sequences of genes assigned to the D19S197–
D19S408 interval (Ashworth et al. 1995) were analyzed
for the presence of di- and trinucleotide repeats through
GenBank. The DNA sequences were analyzed for short
tandem repeat units. Flanking primers were designed in
order to generate specific amplicons. PCR products and
the presence of polymorphisms were detected as de-
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scribed below (DNA analysis). The distribution of alleles
was determined from the analysis of DNA from 20 un-
related healthy individuals.
DNA Analysis
Genomic DNA was extracted from peripheral blood
in accordance with standard procedures. The polymor-
phic dinucleotide repeats D19S200, D19S197, LIPE,
D19S408, and D19S178, assigned to the 19q13 region
(Dib et al. 1996), were amplified from the genomic DNA
of all families, as described elsewhere (Gustavsson et al.
1997b). A newly identified polymorphic repeat, PG1
(GenBank accession number L32754), is located within
the critical DBA gene region between markers D19S197
and LIPE. The PG1 repeat was amplified from the ge-
nomic DNA of the families with the specific primers: 5′-
TGATGTTGCCACAGCACTTC, forward, and 5′-
CTCTCTGAGTCTACAACCAG, reverse. For the anal-
ysis of all microsatellites, PCR was performed at opti-
mized conditions for genomic DNA by the use of primers
end-labeled with g[32P]-ATP. The PCR reactions were
performed in 96 well microtitre plates, in a reaction vol-
ume of 10 ml, with 20 ng of genomic DNA. The PCR
mixture contained 2 pmol of each primer, 0.1 mM of
each of the four deoxytrinucleotide triphosphates, and
0.5 U of Taq DNA polymerase. The PCR conditions
were 4 min at 94C for denaturing, followed by 28 cycles
of 30 s at 94C, 30 s at 55C, and 30 s at 72C. PCR
products were separated on polyacrylamide gels by elec-
trophoresis and were visualized by autoradiography. The
genotypes and the haplotypes were assigned manually.
Linkage Analysis
Linkage analysis was performed in 29 multiplex fam-
ilies, 13 of which were included in a previous study
(Gustavsson et al. 1997b). LOD scores were calculated
in two separate ways. In the first analysis, all families
were considered dominant. In a second analysis, the fam-
ilies who followed a recessive mode of inheritance
( ) were analyzed separately under a recessiven  4
model. Different penetrant models (.7–.9) were used and
the disease-gene frequency was set to 106 with no sex
difference. Allele frequencies were taken from the Ge-
nome Database (GDB) when possible. The order and
distances between the chromosome 19 markers were de-
termined from maps from Ge´ne´thon (Dib et al. 1996),
the chromosome 19 workshop (Mohrenweiser et al.
1996), Lawrence Livermore National Laboratory (Ash-
worth et al. 1995), and GDB. The order of marker loci
is centromere-D19S200-D19S197-PG1-LIPE-D19S408-
D19S178-telomere. Two-point LOD scores were per-
formed by use of FASTLINK version 3.0P (Lathrop et
al. 1984) from the original LINKAGE analysis computer
package (Ott 1991).
FISH Analyses of Microdeletions
Chromosome preparations from three DBA patients
that showed constitutional microdeletions for the 19q13
region were analyzed by FISH. The deletion found in
patient RG was described elsewhere (Gustavsson et al.
1997b). FISH to metaphase chromosomes was per-
formed essentially as described elsewhere (Lichter et al.
1988; Gustavsson et al. 1997a). Cosmid DNA was la-
beled either with biotin or digoxigenin using nick trans-
lation. Hybridization of probes was detected by the
application of a single layer of FITC-avidin (Vector
labs) or rhodamine-labeled antidigoxigenin (Boehringer
Mannheim). Double hybridization was detected by
means of a mixture of FITC-avidin and rhodamine-
labeled antidigoxigenin. Chromosomes were counter-
stained with DAPI (Serva) and mounted in antifade so-
lution (Vector labs). The slides were analyzed with a
Zeiss Axioskop epifluorescence microscope, and the im-
ages were merged by use of a CCD camera (Photome-
trics) and the Quips SmartCapture FISH software
(Vysis).
Cosmids
A physical map has been constructed over the 19q13
region (Ashworth et al. 1995; Mohrenweiser et al.
1996). The chromosome 19 cosmids used were obtained
exclusively from Lawrence Livermore National Labo-
ratory with their corresponding numbers (Ashworth et
al. 1995). In total, seven cosmids were used for FISH
analyses, and their relative order from the centromere
to the telomere is as follows: 9476 (RYR1), 16767
(CYP2A12), 14353 (CGM1), 24450 (ATP1A3), 19343
(D19S336), 9933 (CGM9), and 8764 (XRCC1).
Results
Identification of Polymorphic Short Tandem Repeats
One short tandem repeat was identified by computer
search of the genomic sequences assigned between mark-
ers D19S200 and D19S408. The repeat is localized in
intron 4 of the gene-encoding IGA (CD79a), which maps
between D19S197 and LIPE. The repeat is complex and
consists of a combined dinucleotide and a trinucleotide
repeat (GenBank accession number L32754). The re-
peat, designated PG1, was analyzed for polymorphisms
on the DNA from 20 independent individuals. Separa-
tion of PCR products revealed alleles with a range of
186–218 bp. The degree of heterozygosity was .85 from
20 chromosomes.
Haplotype Analysis of Familial DBA Cases
The most likely haplotypes from the six chromosome
19 markers were constructed when possible. The results
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Figure 1 Three multiplex DBA families with haplotypes spanning the candidate gene locus on chromosome 19q13.2. DNA marker loci
are shown, left, with relative marker order from centromere to telomere. Corresponding marker alleles and haplotypes are boxed and indicated
below each symbol. In each kindred, no common haplotype was inherited by affected relatives, thereby indicating genetic heterogeneity. Asterisks
(*) indicate deduced haplotypes.
from 26 of 29 multiplex families were consistent with
a DBA gene localization on chromosome 19q between
loci D19S200 and D19S178. In three multiplex families,
none of the inherited marker alleles were shared by the
affected family members, respectively (fig. 1). The chance
for a double recombination between two adjacent mark-
ers in the critical region is !.1%. Thus, the most likely
explanation for the results is a DBA locus not localized
to 19q13.2 in these families. Affected individuals of the
three nonlinked families presented elevated levels of
ADA. The clinical picture was typical for DBA (diag-
nostic criteria included age of onset, bone marrow bi-
opsies, reticulocyte counts, and chromosome fragility
tests) and was similar to patients from families in which
the 19q markers cosegregate with DBA. Fetal hemoglo-
bin measurements were available only from affected in-
dividuals of family I (fig. 1), and the levels were found
to be elevated. With the exception of families I–III, no
evidence for genetic heterogeneity was found; however,
in five families with a dominant mode of inheritance for
DBA, the disease-associated chromosome 19 haplotype
was also transmitted to a healthy family member (12
years and normal hemoglobin levels; fig. 2). The levels
of erythrocyte-ADA activity were measured in three of
these healthy siblings, and the activity was found to be
elevated in one of them (family V, ind. II:2; fig. 2). The
results from ADA measurements suggest an incomplete
clinical penetrance in this apparently healthy sibling. The
results obtained from the analysis of families IV and
VI–VIII could be explained either by an incomplete pen-
etrance for the disorder or by genetic heterogeneity. In
one family (family VIII; fig. 2), germinal mosaicism for
a mutant 19q allele is a third possible explanation for
the transmission of identical haplotypes from the healthy
woman in the first generation to her affected and healthy
children, respectively.
Linkage Analysis
The six chromosome 19q markers D19S200,
D19S197, PG1, LIPE, D19S408, and D19S178 were
analyzed. LOD scores were first calculated by use of
an autosomal dominant model for all familial cases (ta-
ble 1). A two-point linkage analysis revealed Z max
at D19S197, with an assumed penetrance of .9.9.93
By the exclusion of the three nonlinked families (family
I, family II, and family III; fig. 1) from the analysis, a
pairwise at D19S197 was obtained. Zmax was fur-Zmax
ther increased to 5.16 by reduction of the penetrance
from .9 to .7.
A second calculation used a dominant model for fam-
ilies that showed a dominant inheritance ( ) andn  25
a recessive model for families with an apparently reces-
sive inheritance ( ). With the assumption of thisn  4
combination of either dominant or recessive inheritance
and a penetrance of .9, a two-point wasZ  5.84max
obtained (dominant families, 2.70; recessive families,
3.14). No evidence for heterogeneity was found with the
HOMOG option from the original LINKAGE analysis
computer package (Lathrop et al. 1984).
Haplotype Analysis of Sporadic DBA Cases
In 50 families that included a sporadic case of DBA,
parents and at least one healthy sibling were analyzed
for the segregation of 19q marker alleles at loci
D19S200, D19S197, PG1, LIPE, D19S408, and
D19S178. Apparent loss of parental alleles was observed
in three affected individuals. The three patients presented
with common clinical features in addition to DBA, in-
cluding mental retardation and skeletal malformations
of the long bones and the spine. Patient MH, who carries
an apparent balanced translocation t(8;19)(q35;q13),
was hemizygous for the microsatellite loci D19S197 and
PG1 with loss of the paternal allele. In patient HC, the
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Figure 2 Segregation of 19q marker alleles in families with dominantly inherited DBA. In each of the five different families, apparently
healthy family members have inherited the disease-associated chromosome 19q haplotype, which suggests incomplete penetrance or locus
heterogeneity. The activity of erythrocyte ADA was measured in families V, VI, and VII; increased ADA level was found in one healthy sibling
(family V, ind. II:2). Normal ADA levels were found in healthy siblings of family VI (individual II:1) and family VIII (individual II:3).
markers D19S197, PG1, and LIPE revealed loss of the
maternal alleles. In patient RG, markers PG1 and LIPE
revealed loss of the paternal alleles (fig. 3). The segre-
gation of marker alleles was analyzed in 93 healthy sib-
lings of patients with sporadic DBA. Forty-eight healthy
siblings shared one inherited 19q13 haplotype with the
proband, 23 shared both 19q13 haplotypes, and 22
shared none. The results indicate an almost random seg-
regation of marker alleles on chromosome 19q to
healthy siblings of sporadic DBA cases.
Mapping the Microdeletions by FISH
FISH analyses of metaphase chromosomes of the three
patients with loss of parental marker alleles confirmed
hemizygosity for part of the 19q13.2 region (fig. 4). The
extremities of the deletions were approximately localized
with cosmids derived from a chromosome 19 map (Ash-
worth et al. 1995; Mohrenweiser et al. 1996). The de-
letion associated with t(8;19)(q35;q13) in patient MH
was mapped between cosmid 16767 on the centromeric
side and 24450 on the telomeric side. Likewise, the de-
letion identified in patient HC was found to extend be-
tween cosmids 16767 and 9933. The microdeletion in
patient RG was previously shown to extend between
cosmids 16923 (TGFB1) and 8764 (XRCC1) (Gustavs-
son et al. 1997b). The proximal breakpoint of the de-
letion was further restricted by cosmid 16767. In sum-
mary, the three deletions define a common overlap
restricted by cosmid 16767 (CYP2A12) on the centrom-
eric side and cosmid 19343 (D19S336) on the telomeric
side (fig. 4). The two cosmids are separated by ∼1 Mb
of DNA (Ashworth et al. 1995), which narrows the DBA
candidate region from 1.8 Mb (Gustavsson et al. 1997b).
Discussion
We previously localized a gene for DBA to a 1.8-Mb
region, with indications for homogeneity (Gustavsson et
al. 1997a, 1997b). Although a majority of familial cases
in this study are consistent with a locus on chromosome
19q13.2, the results from segregation of 19q13 marker
alleles in three families cannot be explained by a primary
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Figure 3 Identification of microdeletions in the 19q13.2 region in three sporadic cases of DBA. Haplotypes reveal hemizygosity on the
paternally derived chromosome of patient MH and patient RG. Patient MH shows loss of markers D19S197 and PG1; patient RG shows loss
of markers PG1 and LIPE. Patient HC is hemizygous for markers D19S197, PG1, and LIPE, with loss of the maternally derived alleles. Patient
RG was presented elsewhere (Gustavsson et al. 1997b).
gene defect in this region. Our results indicate the ex-
istence of at least two genes for DBA. The variable in-
heritance in familial cases with either a dominant or a
recessive pattern, in combination with a variety of clin-
ical abnormalities, has previously led to the suggestion
of genetic heterogeneity for the disorder. This suggestion
has also been supported by in vitro experiments (Tsai et
al. 1989).
When the chromosome 19q13.2 haplotype in each
sporadic patient with DBA was compared with the hap-
lotype inherited by 93 healthy siblings, the results
showed an almost random distribution of inherited al-
leles. This contradicts a recessive inheritance for a gene
on 19q13 and could be explained by new mutations of
a dominant gene on 19q, incomplete penetrance for a
dominant gene, or genetic heterogeneity. The three over-
lapping microdeletions on 19q13 found among the 50
sporadic cases analyzed indicate that de novo rearrange-
ments are one cause of the disease in sporadic cases.
The size of the common overlap of the microdeletions
is ∼1 Mb, and the region spans 110 known genes (Ash-
worth et al. 1995; Mohrenweiser et al. 1996). The cause
of DBA is not known, and the large number of genes
mapped to the deleted interval does not allow us yet to
specify what gene is responsible for the disease. In ad-
dition, there are several expressed sequence tags mapped
to 19q13.2. It is interesting to note that several gene
families are clustered in the region that corresponds to
the microdeletions. At least six copies of the cytochrome
P-450 gene family, which are hemoproteins involved in
the metabolism of steroids and the detoxification of
drugs (Nebert 1991), are clustered in the vicinity of the
proximal breakpoints. In a more telomeric direction, the
carcinoembryonic antigen (CEA) gene family, which in-
cludes the CEA gene-family members and the pregnancy-
specific glycoprotein gene families, are represented by
several copies (Thompson et al. 1992; Teglund et al.
1994). The CEA gene family encodes a large family of
glycoproteins with an unknown function. Tandemly re-
peated and homologous sequences may be predisposed
to homologous unequal recombination. Such events
have been suggested to be the mechanisms for micro-
deletions in chromosome 17p11.2 associated with
Smith-Magenis syndrome (Chen et al. 1997); however,
a similar mutation mechanism needs to be confirmed by
DNA sequencing of the deletion breakpoints in our
patients.
A substantial proportion of patients with DBA have
associated features, in addition to anemia. Common as-
sociated malformations affect the hand and the thumb,
but skeletal abnormalities of the head have also been
observed. These phenotypes may result from contiguous
deletions that involve several genes or from mutations
in a single gene important both for hematopoiesis and
skeletal development. We identified three patients with
overlapping deletions associated with skeletal abnor-
malities that affect the extremities, the skull, and the
spine, as well as mental retardation, which has been
reported previously in some patients with DBA (Janov
et al. 1996). These overlapping deletions suggest the in-
volvement of several genes as the cause of the phenotype
of patients MH, HC, and RG. Further molecular studies
of patients with complex features and DBA may clarify
whether their phenotypes are caused by microdeletions.
Our combined results suggest genetic heterogeneity
for DBA, of which the majority of multiplex families
appear linked to a gene on chromosome 19q. In addi-
tion, a proportion of sporadic cases result from new
mutations of a gene on 19q13.2, of which three de novo
microdeletions indicate a critical gene region for DBA.
The detailed mapping of these deletions may indicate
candidate genes for overlapping phenotypes that include
mental retardation and skeletal malformations. Further
linkage studies in families not linked to chromosome
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Figure 4 Continuous physical map of part of the 19q13.2 region (top); includes known markers and genes found on a previously presented
physical map (Ashworth et al. 1995). Asterisks (*) indicate transcribed genes in the critical interval. The extent of the three microdeletions are
shown (below). Horizontal bars represent chromosome regions present in the three patients. The deleted regions in each patient are indicated
by an intervening line, respectively. The critical DBA gene region, indicated by a two-headed arrow (Rr), is restricted by cosmids 16767 and
19343.
19q13 are required in order to identify a second DBA
locus. We suggest that in certain multiplex families, and
in sporadic families in general, great care should be taken
when using polymorphic 19q markers for diagnosis and
genetic counseling.
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